I previously mentioned there is an alleged theory concerning one of the Project Stargate investors involvement with an AI or ML diagnostics tool that allegedly performs better than traditional cardiac diagnostics tools (EEGs and EKGs). Today we have the following FDA announcement. Is part of the MAHA plan to look at cardiac issues from the injections? I do not know but there is also talk in the news about patents as well and there have been previous concerns about intellectual property issues and patents. Perhaps it is worth considering we need to see how this plays out.

https://www.fiercebiotech.com/medtech/fdas-diagnostics-cmo-named-interim-agency-commissioner